<table><thead><tr><th rowspan="3">Second primary<br>malignancy site</th><th colspan="9">First primary NHL subtype</th><th rowspan="3">P<sub>heterogeneity</sub><sup>*</sup></th></tr><tr><th colspan="3">CLL/SLL</th><th colspan="3">DLBCL</th><th colspan="3">FL</th><th colspan="3">MZL</th></tr><tr><th>Obs</th><th>SIR†</th><th>95% CI†</th><th>Obs</th><th>SIR†</th><th>95% CI†</th><th>Obs</th><th>SIR†</th><th>95% CI†</th><th>Obs</th><th>SIR†</th><th>95% CI†</th></tr></thead><tbody><tr><td>Oropharynx/tonsil</td><td>30</td><td>1.08</td><td>0.73-1.54</td><td>22</td><td>1.04</td><td>0.65-1.58</td><td>18</td><td>1.00</td><td>0.59-1.58</td><td>7</td><td>0.96</td><td>0.39-1.98</td><td>.99</td></tr><tr><td>Stomach</td><td>39</td><td>0.70‡</td><td>0.50-0.96</td><td>62</td><td>1.51‡</td><td>1.16-1.94</td><td>26</td><td>0.81</td><td>0.53-1.19</td><td>44</td><td>2.78‡</td><td>2.02-3.74</td><td>&lt;.01</td></tr><tr><td>Anus</td><td>16</td><td>1.57</td><td>0.90-2.55</td><td>31</td><td>3.71‡</td><td>2.52-5.27</td><td>5</td><td>0.67</td><td>0.22-1.56</td><td>8</td><td>2.36‡</td><td>1.02-4.64</td><td>&lt;.01</td></tr><tr><td>Liver</td><td>54</td><td>1.04</td><td>0.78-1.36</td><td>76</td><td>1.85‡</td><td>1.46-2.31</td><td>32</td><td>0.98</td><td>0.67-1.39</td><td>30</td><td>1.98‡</td><td>1.34-2.83</td><td>&lt;.01</td></tr><tr><td>Cervix uteri</td><td>7</td><td>0.78</td><td>0.31-1.61</td><td>9</td><td>0.89</td><td>0.41-1.69</td><td>8</td><td>0.87</td><td>0.38-1.72</td><td>&lt;5</td><td>0.68</td><td>0.14-1.98</td><td>.98</td></tr></tbody></table>